Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

VilaJ_Clin_Microbiol_Infect_2019_Postprint.pdf (456.33 KB)

Document type

Article

Version

Accepted version

Publication date

2019-09-28

Publication license

cc by-nc-nd (c) European Society of Clinical Microbiology and Infectious Diseases
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/143778

Current landscape in the discovery of novel antibacterial agents

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/ 10.1016/j.cmi.2019.09.015

Abstract

Background: Standard treatments against bacterial infections are becoming ineffective due to the rise of antibacterial resistance worldwide. Classical approaches to develop new antibacterial agents are not sufficient to fulfil the current pipeline, therefore new strategies are currently being devised in the field of antibacterial discovery. Objectives: The objective of this narrative review is to compile the most successful strategies for drug discovery within the antibacterial context that are currently being pursued. Sources: Peer-reviewed publications from the MEDLINE database with robust data addressing the discovery of new antibacterial agents in the current pipeline have been selected. Content: Several strategies to discover new antibacterials are described in this review: (i) derivatives of known antibacterial agents; the activity of a known antimicrobial agent can be improved through two strategies: (a) the modification of the original chemical structure of an antimicrobial agent to circumvent antibacterial resistance mechanisms and (b) the development of a compound that inhibits the mechanisms of resistance to an antibacterial agent; (ii) new antibacterial agents targeting new proteins; (iii) inhibitors of virulence factors; (iv) nanoparticles; (v) antimicrobial peptides and peptidomimetics; (vi) phage therapy and enzybiotics; and (vii) antisense oligonucleotides. Implications: This review intends to provide a positive message affirming that several different strategies to design new antibacterial agents are currently being developed, and we are therefore confident that in the near future some of the most promising approaches will come to fruition.

Subject

Medicaments antibacterians, Antibiòtics

Subject (English)

Antibacterial agents, Antibiotics

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

VILA ESTAPÉ, Jordi, MORENO-MORALES, Javier and BALLESTÉ DELPIERRE, Clara Celia. Current landscape in the discovery of novel antibacterial agents. Clinical Microbiology and Infection. 2019. ISSN 1198-743X. [consulted: 8 of August of 2026]. Available at: https://hdl.handle.net/2445/143778

Export metadata

JSON - METS

Share record